🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate the effectiveness and safety of...
Status
Completed
Location
Multiple Locations
Start Date
2002-11
Trial ID
NCT00214526
Treatments Being Tested
Because approximately half of all mild-moderately-severe asthma is persiste...
Status
Completed
Location
University of Arizona College of Medicine
Start Date
2014-07
Trial ID
NCT02066298
Treatments Being Tested
Objective: To evaluate non-inferiority of Trimbow, an approved therapy for ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-02-15
Trial ID
NCT04737655
The purpose of this Phase III study is to evaluate the efficacy and safety ...
Status
Completed
Location
Research Site
Start Date
2022-01-03
Trial ID
NCT05166889
Treatments Being Tested
The mission of SARP is to improve the understanding of severe asthma throug...
Status
Completed
Location
University of California, San Francisco
Start Date
2012-11
Trial ID
NCT01718197
To establish the feasibility of stopping inhaled steroids and switching or ...
Status
Completed
Location
Prince Philip Hospital
Start Date
2017-05-17
Trial ID
NCT03527927
Treatments Being Tested
The aim of this randomized controlled trial is to investigate the effects o...
Status
Recruiting
Location
Örebro University Hospital
Start Date
2024-08-20
Trial ID
NCT06307418
Treatments Being Tested
The primary purpose of this study is to demonstrate the equivalence of bude...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-17
Trial ID
NCT06340581
Study involving undertaking research interviews with adults who have primar...
Status
Recruiting
Location
University Hospitals Southampton NHS Trust
Start Date
2025-09-02
Trial ID
NCT07357558
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested